Cardax, Inc. (CDXI)
OTCMKTS · Delayed Price · Currency is USD
0.000001
-0.000099 (-99.00%)
At close: Mar 12, 2026
Cardax Market Cap
Cardax has a market cap or net worth of $1 as of March 30, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
1.00
Enterprise Value
n/a
Revenue
500.71K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 10, 2014, Cardax's market cap has decreased from 191.71M to 1.00, a decrease of -100.00%. That is a compound annual growth rate of -79.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 1.00 | -98.80% |
| Dec 9, 2025 | 83.00 | - |
| Dec 31, 2024 | 83.00 | -49.70% |
| Dec 27, 2022 | 165.00 | -99.96% |
| Dec 30, 2021 | 412.79K | -68.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurobiological Technologies | 27.00 |
| TetraLogic Pharmaceuticals | 24.00 |
| Verde Science | 24.00 |
| Sienna Biopharmaceuticals | 23.00 |
| IMV Inc. | 15.00 |
| PhaseRx | 12.00 |
| ContraFect | 11.00 |
| Notable Labs | 10.00 |